Please enable JavaScript.

Coggle requires JavaScript to display documents.

Obesity - Coggle Diagram

- - - - MOA: Inhibition of pancreatic lipase - reducing absorption of triglycerides
      - Dicontinue after 12w if loss of 5% body weight not achieves
    - - Examples
        
        Liraglutide / Saxenda
      - Indication
        
        BMI > 30
        BMI > 27 + weight related comorbidity
      - Risks / SE
        
        Acute pancreatitis
        
        Exacerbation of thyroid disease
        
        Hypoglycaemia
        
        Headaches / dizziness
        
        GI upset
        
        Diabetic retinopathy
  - - - Reduced risk of diabetes
      - Increased chance of remission from diabetes
      - Greater short and long term weight loss
    - - Acute surgical complications
        Leaks, perf, obstruction, infection, haemorrhage, hypoglycaemia
      - Anaemia
      - B12 deficiency
      - Thiamine deficiency
      - Over-restriced gastric band
      - Weight regain
- - - - Older people
      - Intellectual disabiloty
      - Disadvantage areas
      - Mental health problems
      - Women pre-pregnancy, in pregnancy or postpartum
      - Smoking cessation
      - Menopause
    - - Pre and postnatal care
      - Chronic disease managment appointment
      - Medication reviews
      - Childhood/ adolescence/ young adults
    - - Ask
      - Assess
      - Advise
      - Agree
      - Assis
  - - - Disease in which excess bodyfat has accumulated to an extent that health is adversely affected
    - - BMI : Weight / height
      - Waist to hip ratio
      - Waist circumference
    - - Athletic / muscular people
      - Underestimating body fat in older people
      - Ethnicity
- - - - BMI 25-29.9
    - - Class I: BMI 20-34.9
      - Class II: BMI of 35-39.9
      - Class III: BMI of => 40
  - - - => 85th percentile on CDC charts
    - - =>95th pertentile on CDC charts